Ernest Pharmaceuticals, Inc.

Hadley, MA

UEI
MKSZL7C5T1G5
CAGE
7M9Y0
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
2 Ladyslipper Ln, Hadley, MA 01035, USA
Website
ernestpharma.com
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Sbir phase II: a bacterial intracellular delivery platform for liver cancer 2035560 Division of Industrial Innovation $1,000,000
Bacterial delivery of pro-apoptotic proteins in advanced hepatocellular carcinoma. R43CA250941 National Cancer Institute (NIH) $284,249
Bacterial delivery of phosphatase antagonists to metastatic breast cancer R43CA233136 National Cancer Institute (NIH) $217,089
Sbir phase i: a bacterial intracellular delivery platform for liver cancer 1819794 Division of Industrial Innovation $225,000

Quick answers

Is Ernest Pharmaceuticals, Inc. registered in SAM.gov?

Yes. Ernest Pharmaceuticals, Inc.'s SAM.gov registration is active through June 11, 2027.

What is Ernest Pharmaceuticals, Inc.'s most recent federal award?

Ernest Pharmaceuticals, Inc.'s most recent federal grant award is Sbir phase II: a bacterial intracellular delivery platform for liver cancer (2035560), from Division of Industrial Innovation, on January 15, 2021.

On GovTribe

See Ernest Pharmaceuticals, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login